Jane M. Love > Gibson, Dunn & Crutcher LLP > New York, United States > Lawyer Profile

Gibson, Dunn & Crutcher LLP’s practice is adept at the full range of IP litigation, often representing leading tech and telecoms companies, such as Verizon and T-Mobile. In this vein, the team recently scored a victory for Verizon regarding 5G wireless technology patent infringement. The practice is also well-equipped to defend its clients against non-practicing entities. With the ability to litigate complex patent cases from discovery to trial and appeal, Kate Dominguez co-chairs the department with fellow litigators Josh Krevitt and Jane Love. Krevitt focuses on high-stakes patent litigation spanning wireless technologies, ANDA litigation, telecommunications hardware and semiconductors. The ‘compelling and persuasive’ Jane Love specialises in pharmaceutical and biotechnology patents, with extensive experience in Hatch-Waxman and BPCIA cases. Brian Rosenthal, who clients laud as ‘one of the best trial lawyers’ observed in court, is another key tech patent litigator, with particular success at the Court of Appeals. Additionally, in Washington DC, Brian Buroker brings well-rounded experience in different patents, spanning the medical device, pharma and high-tech sectors. All named attorneys are based in New York unless otherwise stated.

Notably active across the sectors of media, consumer products software and tech, Gibson, Dunn & Crutcher LLP offers a varied practice which encompasses trademark, trade dress, false advertising and internet commerce issues. Four key players lead the practice: namely, Kate Dominguez, Ernest Hsin, Josh Krevitt and Jane Love. Ilissa Samplin, who operates from the firm’s Los Angeles office, demonstrates prowess in the realm of tech and entertainment disputes, while Washington DC-based Howard S. Hogan bolsters the practice with his extensive contentious expertise. In New York, Orin Snyder is well-positioned to advise on copyright infringement, trademark infringement, and unfair competition litigation mandates.

Gibson, Dunn & Crutcher LLP’s life sciences practice represents biotech, pharma, and medical device companies in IP and corporate and commercial transactions. The firm has a strong transactional team advising both issuers and financial institutions in deals across M&A, venture financing, stock and asset acquisitions, and private and public securities offerings. Its patent litigation expertise includes cases under the Hatch-Waxman Act, as well as the enforcement of second- and third-generation, combination drug, and formulation patents. The practice is co-chaired by San Francisco’s Ryan Murr, who is vastly experienced in capital markets transactions, M&A, royalty financing, and corporate governance. Also co-chair, New York-based Jane Love handles high-value patent litigation, patent prosecution, and diligence advice connected to transactions.